Gsk Plc (GSK.LN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [LSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [LSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | GSK.LN | ||||
| Company | Gsk Plc | ||||
| Price Information | |||||
| Exchange | LSE | ||||
| Open | 1,826.500 | ||||
| High | 1,833.500 | ||||
| Low | 1,797.500 | ||||
| Latest | 1,805.000 | ||||
| Change | -21.000 | ||||
| % Change | -1.15% | ||||
| Volume | 4,274,873 | ||||
| 20-Day Average Volume | 8,975,388 | ||||
| Previous Close | 1,826.000 | ||||
| Industry | N/A | ||||
| Has Options | No | ||||
| Technicals | |||||
| 20-Day Moving Average | 1,799.463 | ||||
| 20-Day Raw Stochastic | 51.74% | ||||
| 20-Day Relative Strength | 60.24 | ||||
| Weighted Alpha | +40.11 | ||||
| Today's Opinion | 100% Buy | ||||
| Previous Opinion | 100% Buy | ||||
| Last Month's Opinion | 100% Buy | ||||
| Performance | |||||
| 5-Days | |||||
| %Chg | +0.78% since 11/28/25 | ||||
| Low | 1,781.000 on 12/02/25 | ||||
| High | 1,853.500 on 12/04/25 | ||||
| 1-Month | |||||
| %Chg | +0.95% since 11/05/25 | ||||
| Low | 1,753.000 on 11/21/25 | ||||
| High | 1,853.500 on 12/04/25 | ||||
| 3-Month | |||||
| %Chg | +22.29% since 09/05/25 | ||||
| Low | 1,445.000 on 09/08/25 | ||||
| High | 1,853.500 on 12/04/25 | ||||
| 6-Month | |||||
| %Chg | +19.38% since 06/05/25 | ||||
| Low | 1,288.605 on 08/21/25 | ||||
| High | 1,853.500 on 12/04/25 | ||||
| Key Statistics | |||||
| Market Capitalization, $K | 74,000,448 | ||||
| Shares Outstanding, K | 4,037,622 | ||||
| Annual Sales | 31,376,000,000 | ||||
| Annual Net Income | 2,575,000,000 | ||||
| Last Quarter Sales | 8,547,000,000 | ||||
| Last Quarter Net Income | 2,013,000,000 | ||||
| 60-Month Beta | N/A | ||||
| Per-Share Information | |||||
| Most Recent Earnings | 0.49 on 10/29/25 | ||||
| Latest Earnings Date | N/A | ||||
| Most Recent Dividend | 0.160 on 11/13/25 | ||||
| Next Ex-Dividends Date | 11/13/25 | ||||
| Ratios | |||||
| Price/Earnings ttm | 13.78 | ||||